Vimarsana
Biggest News Aggregation in the World

Page 14 - Pharma Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Intelligence Today - Breaking & Trending Today

Kidney Disease (Nephropathy) accounts for 50.6% share of global Genito Urinary System And Sex Hormones clinical trial activity in 2021 - Vimarsana News

Kidney Disease (Nephropathy) accounts for 50.6% share of global Genito Urinary System And Sex Hormones clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...

Mycobacterium Infections accounts for 1.9% share of global Infectious Disease clinical trial activity in 2021 - Vimarsana News

Mycobacterium Infections accounts for 1.9% share of global Infectious Disease clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...

Investegate |Informa Business Intelligence Announcements | Informa Business Intelligence: Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review - Vimarsana News

Investegate |Informa Business Intelligence Announcements | Informa Business Intelligence: Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

Investegate announcements from Informa Business Intelligence, Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

Informa minds the GAP II with revenue and profits growth - Vimarsana News

Informa minds the GAP II with revenue and profits growth

Annual results from Informa show increase revenues and profits.

US drug regulatory authority declines to grant emergency use authorisation for Covaxin for children - Vimarsana News

US drug regulatory authority declines to grant emergency use authorisation for Covaxin for children

Ocugen is developing it in the US and Canada after acquiring rights for the vaccine from the Hyderabad-based Bharat Biotech